Patent ID: 6440471
Filing Date: 2002-08-27
Classification: A23L,A23V,A61K,Y02A

Abstract:
A method of preventing or treating a urogenital infection in a mammal comprising administering an effective amount of a pharmaceutical composition having a peak located at about 95 ppm on a 13C NMR, said composition consisting essentially of proanthocyanidin compounds having an average of from at least four to about seven epicatechin flavanoid units, wherein at least two of said units are linked together by an A-type interflavanoid linkage by bonds between C4 and C8 and between the C2 and the oxygen of C7 of the units and the remainder of the units are linked to each other by a B-type interflavanoid bond between C4 and C8 or between C4 and C6 of the units, wherein said composition is admixed with a pharmaceutically acceptable carrier.